Float Short %

16.48

Margin Of Safety %

Put/Call OI Ratio

1.12

EPS Next Q Diff

0.29

EPS Last/This Y

3.7

EPS This/Next Y

3.7

Price

53.64

Target Price

118.73

Analyst Recom

1.09

Performance Q

-33.14

Relative Volume

2.04

Beta

-2.76

Ticker: SLNO

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	SLNO	71.64	1.07	1.89	38227
2025-08-18	SLNO	68.1	1.27	0.54	35615
2025-08-19	SLNO	66.8	1.23	0.58	37403
2025-08-20	SLNO	68.9	1.23	0.95	37506
2025-08-21	SLNO	69.78	1.22	1.96	38429
2025-08-22	SLNO	68.61	1.23	1.88	38788
2025-08-25	SLNO	66.46	1.23	0.35	38898
2025-08-26	SLNO	69.58	1.19	0.09	38205
2025-08-27	SLNO	67.32	1.19	1.72	38270
2025-08-28	SLNO	68.38	1.23	0.04	39086
2025-08-29	SLNO	67.27	1.21	2.67	38891
2025-09-02	SLNO	67.19	1.21	0.15	38888
2025-09-03	SLNO	66.9	1.21	0.04	38923
2025-09-04	SLNO	69.51	1.21	6.36	38949
2025-09-05	SLNO	69.74	1.23	0.03	39444
2025-09-08	SLNO	72.3	1.22	10.09	39673
2025-09-09	SLNO	69.85	1.22	0.01	39668
2025-09-10	SLNO	60.01	1.20	0.84	39977
2025-09-11	SLNO	56.68	1.15	0.81	47665
2025-09-12	SLNO	53.66	1.12	0.57	50335
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	SLNO	71.68	-	-	0.00
2025-08-18	SLNO	68.07	-	-	0.00
2025-08-19	SLNO	66.81	-	-	-0.81
2025-08-20	SLNO	69.00	-	-	-0.81
2025-08-21	SLNO	69.79	-	-	-0.80
2025-08-22	SLNO	68.53	-	-	-0.80
2025-08-25	SLNO	66.45	-	-	-0.70
2025-08-26	SLNO	69.61	-	-	-0.70
2025-08-28	SLNO	68.41	-	-	-0.70
2025-08-29	SLNO	67.57	-	-	-0.70
2025-09-02	SLNO	67.21	-	-	-0.70
2025-09-03	SLNO	66.97	-	-	-0.70
2025-09-04	SLNO	69.52	-	-	-0.70
2025-09-05	SLNO	69.77	-	-	-0.69
2025-09-08	SLNO	72.30	-	-	-0.69
2025-09-09	SLNO	70.18	-	-	-0.69
2025-09-10	SLNO	60.22	-	-	-0.69
2025-09-11	SLNO	56.72	-	-	-0.69
2025-09-12	SLNO	53.64	-	-	-0.69
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	SLNO	-25.59	10.88	13.55
2025-08-18	SLNO	-25.59	30.37	13.30
2025-08-19	SLNO	-27.62	30.37	13.14
2025-08-20	SLNO	-29.14	30.37	13.14
2025-08-21	SLNO	-29.14	30.37	13.14
2025-08-22	SLNO	-29.13	30.37	13.14
2025-08-25	SLNO	-29.13	13.78	13.14
2025-08-26	SLNO	-29.13	13.78	13.14
2025-08-27	SLNO	-29.13	13.78	13.72
2025-08-28	SLNO	-29.13	13.78	13.72
2025-08-29	SLNO	-29.13	13.78	13.72
2025-09-02	SLNO	-29.13	13.83	13.72
2025-09-03	SLNO	-29.13	13.83	13.72
2025-09-04	SLNO	-29.13	13.83	13.72
2025-09-05	SLNO	-29.13	13.83	13.72
2025-09-08	SLNO	-29.13	13.98	13.72
2025-09-09	SLNO	-29.13	13.98	13.72
2025-09-10	SLNO	-29.13	13.98	13.72
2025-09-11	SLNO	-29.13	13.98	16.49
2025-09-12	SLNO	-29.13	13.98	16.48
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.09

Avg. EPS Est. Current Quarter

0.05

Avg. EPS Est. Next Quarter

0.2

Insider Transactions

-29.13

Institutional Transactions

13.98

Beta

-2.76

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

40.6

Max Drawdown 5-Year %

-98.2

Target Price

118.73

P/E

Forward P/E

17.85

PEG

P/S

87.25

P/B

11.26

P/Free Cash Flow

EPS

-4.15

Average EPS Est. Cur. Y

-0.69

EPS Next Y. (Est.)

3.01

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-554.49

Relative Volume

2.04

Return on Equity vs Sector %

-100.3

Return on Equity vs Industry %

-87.1

EPS 1 7Days Diff

EPS 1 30Days Diff

1.14

EBIT Estimation

Soleno Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 133

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.

stock quote shares SLNO – Soleno Therapeutics Inc Stock Price stock today

news today SLNO – Soleno Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch SLNO – Soleno Therapeutics Inc yahoo finance google finance

stock history SLNO – Soleno Therapeutics Inc invest stock market

stock prices SLNO premarket after hours

ticker SLNO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: SLNO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y